COVID-19 and Patients with Muscular Dystrophy: How Did the Pandemic Affect Patients and Their Medical Care?
PDF
Cite
Share
Request
Clinical Research
VOLUME: 34 ISSUE: 2
P: 159 - 165
2024

COVID-19 and Patients with Muscular Dystrophy: How Did the Pandemic Affect Patients and Their Medical Care?

Anatol J Gen Med Res 2024;34(2):159-165
1. İzmir University of Economics Faculty of Medicine, Department of Internal Sciences/Physical Medicine and Rehabilitation, İzmir, Turkey
2. İzmir Bakırçay University Faculty of Medicine, Department of Physical Medicine and Rehabilitation, İzmir, Turkey
3. University of Health Sciences Turkey, İzmir Tepecik Education and Training Hospital, Clinic of Neurology, İzmir, Turkey
4. University of Health Sciences Turkey, İzmir Tepecik Education and Training Hospital, Clinic of Neuromuscular Diseases, İzmir, Turkey
5. University of Health Sciences Turkey, İzmir Tepecik Education and Training Hospital, Clinic of Pediatric Neurology, İzmir, Turkey
No information available.
No information available
Received Date: 2023-06-21T10:21:29
Accepted Date: 2024-08-12T09:57:54
PDF
Cite
Share
Request

Abstract

Objective: This study investigated the effects of Coronavirus disease-2019 (COVID-19) related lockdowns and the pandemic in patients with muscular dystrophy who require regular hospital admissions and follow-ups. Moreover, the effects of “fear of COVID-19” on these effects were also measured.

Methods: One hundred and five muscular dystrophy patients who were admitted to the neuromuscular diseases tertiary care clinic were evaluated. The patients’ socio-demographic and clinical characteristics were recorded, and their fear of COVID-19 was assessed using the “fear of COVID-19 scale”, and they were asked about the problems they encountered during the pandemic and lockdowns.

Results: We found that the patients had major restrictions in their access to healthcare, physical therapy/rehabilitation, and reduced physical and social activities. Moreover, they subjectively stated that their disease worsened with the pandemic. These restrictions were found to correlate with their fear of COVID-19 levels.

Conclusion: Patients with muscular dystrophy were found to have changes in their physical activity, participation in rehabilitation, problems with reaching healthcare services, and social problems. These problems were associated with their fear of COVID-19. As routine access to healthcare and therapies is crucial for these patients, both patients and health professionals should keep the potential harm of restrictions and fear in mind and strive for optimal solutions.

Keywords:
Neuromuscular diseases, muscular dystrophy, COVID-19, medical care, rehabilitation